The MDA-MB-231-shPSMB7 cells were more sensitive to CIS treatment, which is correlated with enhanced ubiquitination and increased cleaved caspase 3 in the tumor (Supplementary Fig. S6e, f). The gene discussed is CASP3; the disease is in situ carcinoma.